Single-Sequence One-Stop Ferumoxytol-Enhanced Vascular Lumen and Wall Imaging (SSO-FE-VLWI) for Comprehensive Cardiovascular Assessment
Motivation: Current ferumoxytol-enhanced MRA protocols focus on lumen imaging, requiring additional sequences for vessel wall assessment, which increases scan times and motion artifacts. Goal(s): To assess the feasibility and effectiveness of Single-Sequence One-Stop Ferumoxytol-Enhanced Vascular Lumen and Wall Imaging (SSO-FE-VLWI) for simultaneous visualization of the vascular lumen and vessel wall in a single rapid acquisition. Approach: Ten patients with atherosclerosis underwent SSO-FE-VLWI. T2-DIR was used for vessel wall validation, with comparison to non-enhanced in-phase images. Results: SSO-FE-VLWI provided clear delineation of both the vascular lumen and vessel wall, showing significantly greater vessel wall visualization compared to non-enhanced imaging, with spatial overlap validating accuracy. Impact: SSO-FE-VLWI provides a time-efficient approach for comprehensive vascular evaluation, reducing the need for additional sequences and improving clinical workflow.
Authors
- Jiaqi Wei (ORCID: https://orcid.org/0000-0002-3807-9338)
- Guangyan Wu (ORCID: https://orcid.org/0000-0002-7969-0192)
- Peng Han (ORCID: https://orcid.org/0000-0001-7271-9952)
- P Wang
- Guangxiang Si (ORCID: https://orcid.org/0009-0009-0835-3648)
- Pu‐Yeh Wu (ORCID: https://orcid.org/0000-0002-9216-025X)
- Chuanshuai Tian (ORCID: https://orcid.org/0000-0003-4368-0985)
- Min Zhou (ORCID: https://orcid.org/0000-0003-3707-1542)
- Ning Gu
- Dan Mu (ORCID: https://orcid.org/0000-0002-4860-2620)
Publication Details
- Journal
- Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
- Published
- 2025-09-16
- DOI
- https://doi.org/10.58530/2025/5267
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00